Advancing Clinical Trial Design for Non-Muscle Invasive Bladder Cancer

Overview of attention for article published in Bladder Cancer, September 2023

Altmetric Badge

Mentioned by

twitter: 38 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 1 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 50 X posts from 38 X users, with an upper bound of 119,813 followers.

RT @drenriquegrande: ⚡️ Advancing Clinical Trial Design for Non-Muscle Invasive Bladder Cancer #bladderCancer #Immunotherapy https://t.co…

Reply Repost Favourite

RT @drenriquegrande: ⚡️ Advancing Clinical Trial Design for Non-Muscle Invasive Bladder Cancer #bladderCancer #Immunotherapy https://t.co…

Reply Repost Favourite

RT @drenriquegrande: ⚡️ Advancing Clinical Trial Design for Non-Muscle Invasive Bladder Cancer #bladderCancer #Immunotherapy https://t.co…

Reply Repost Favourite

⚡️ Advancing Clinical Trial Design for Non-Muscle Invasive Bladder Cancer #bladderCancer #Immunotherapy https://t.co/uvxl3NjKLn https://t.co/1EdW89rUzz

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 46 additional X posts.